Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elective Percutaneous Coronary Intervention”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Post-approval studies (Phase 4)Study completedNCT02748330
What this trial is testing

Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus, Type 2
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)UnknownNCT00765908
What this trial is testing

Ischaemic Pre-Conditioning in Elective Percutaneous Coronary Intervention (PCI) Patients

Who this might be right for
Coronary Artery Disease
University Health Network, Toronto 20
Large-scale testing (Phase 3)Study completedNCT01031095
What this trial is testing

(A Novel Pharmacologic Regime for Elective Percutaneous Coronary Intervention)

Who this might be right for
Coronary Artery Disease
Bursa Postgraduate Hospital 200
Post-approval studies (Phase 4)UnknownNCT00716001
What this trial is testing

Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure

Who this might be right for
Chronic Renal Failure
Osaka General Medical Center
Post-approval studies (Phase 4)Looking for participantsNCT06089577
What this trial is testing

Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention

Who this might be right for
Coronary Artery Disease
Federico II University 80
Not applicableActive Not RecruitingNCT07010965
What this trial is testing

SAVE-PCI: NyokAssist™ Small-Bore VAD vs. IABP in Elective High-Risk PCI

Who this might be right for
High-Risk PCI
magAssist, Inc. 236
Post-approval studies (Phase 4)Study completedNCT03437044
What this trial is testing

Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery Disease
University of Florida 40
Not applicableEnded earlyNCT01190072
What this trial is testing

Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

Who this might be right for
Coronary Artery Disease
AstraZeneca 120
Large-scale testing (Phase 3)Study completedNCT00330928
What this trial is testing

SPECTACL: SPECTroscopic Assessment of Coronary Lipid

Who this might be right for
Angina PectorisAngina, UnstableMyocardial Infarction
Infraredx 106
Not applicableLooking for participantsNCT07485088
What this trial is testing

Video-based Intervention to Reduce Anxiety in Patients Undergoing Elective PCI

Who this might be right for
Procedural AnxietyCoronary Artery DiseasePercutaneous Coronary Intervention Patients
Tan Tock Seng Hospital 144
Large-scale testing (Phase 3)Study completedNCT00432120
What this trial is testing

Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?

Who this might be right for
Ischemic Heart Disease
Charles University, Czech Republic
Testing effectiveness (Phase 2)Study completedNCT00479895
What this trial is testing

Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization

Who this might be right for
Coronary OcclusionAcute Coronary Syndrome
Biopure Corporation 5
Not applicableActive Not RecruitingNCT04477603
What this trial is testing

Impella ECP Early Feasibility Study

Who this might be right for
High-risk Percutaneous Coronary Intervention
Abiomed Inc. 100
Not applicableStudy completedNCT04120961
What this trial is testing

Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)

Who this might be right for
Coronary Heart Disease
Nanjing First Hospital, Nanjing Medical University 330
Not applicableUnknownNCT04239404
What this trial is testing

Prognostic Impact of PMI in Stable CAD Undergoing PCI

Who this might be right for
Periprocedural Myocardial InjuryCoronary Artery DiseasePercutaneous Coronary Intervention
Shanghai Zhongshan Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT00291902
What this trial is testing

A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention

Who this might be right for
Coronary Heart Disease
GlaxoSmithKline 80
Large-scale testing (Phase 3)Study completedNCT01521845
What this trial is testing

Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)

Who this might be right for
Coronary Arteriosclerosis
Shahid Beheshti University of Medical Sciences 104
Not applicableStudy completedNCT01986621
What this trial is testing

Myocardial Injury After Elective Coronary Stenting

Who this might be right for
Coronary Artery Disease
University Hospital Heidelberg 530
Not applicableStudy completedNCT02581618
What this trial is testing

Remote Ischemic Preconditioning in Elective Percutaneous Interventions

Who this might be right for
Myocardial IschemiaIschemic Reperfusion Injury
Trakya University 102
Not applicableStudy completedNCT05387902
What this trial is testing

Short-term Outcomes of Elective High-risk PCI With Extracorporeal Membrane Oxygenation Support: a Single-centre Registry

Who this might be right for
Coronary Artery Disease
Robert Jan van Geuns 25
Load More Results